Volume 19, Number 9—September 2013
CME ACTIVITY - Research
Mumps Postexposure Prophylaxis with a Third Dose of Measles-Mumps-Rubella Vaccine, Orange County, New York, USA
, Jacqueline Lawler, Aaron T. Curns, Christina Brandeburg, and Gregory S. Wallace
Table 3
Demographic characteristics, median number of months since second MMR vaccine dose, and number of mumps case-patients among household members, Orange County, New York, USA, 2009–2010*
Characteristic
Received 3rd MMR dose as PEP, n = 28
Had 2 previous MMR vaccine doses, received no PEP, n = 77
p value
Sex
M
16 (57.1)
29 (37.7)
0.19
F
12 (42.9)
47 (61.0)
Unknown
0
1 (1.3)
Age, y
4–6
10 (35.7)
21 (27.3)
0.58
7–17
17 (60.7)
50 (64.9)
>18
1 (3.6)
6 (7.8)
Median no. months since 2nd MMR dose, IQR
120 (62–177)
139 (62–210)
0.47
Minimum–maximum no. months
32–468
10–468
Mumps onset, attack rate†
0
4 (5.2)
0.57
*MMR, measles-mumps-rubella vaccine; PEP, postexposure prophylaxis; IQR, interquartile range; values are no. (%) unless otherwise indicated.
†Onset of mumps occurred 12–25 days after onset of mumps in index case-patient.